Background and aims The effect of statin therapy on plasma adiponectin levels has not been
conclusively studied. Therefore, we aimed to evaluate this effect through a systematic review …

In experimental studies, statins have been shown to lower blood pressure through increased
nitric oxide bioavailability and improved arterial compliance. The clinical significance of this …

目的: 探讨氨氯地平阿托伐他汀钙片对高血压合并冠心病的临床疗效. 方法: 选取我院于2008 年6
月-2011 年12 月收治的高血压合并冠心病确诊患者58 例, 并在知情同意的前提下将其随机平均 …

Statins have been proven to be effective in minimizing the risk of cardiovascular adverse
events, however, their effect on BP variability is debatable with respect to their significance …

Statins represent the elective lipid-lowering strategy in hyperlipidemic and high
cardiovascular-risk patients. Despite excellent safety and tolerability, reversible muscle …

BACKGROUND: Rosuvastatin and pravastatin have differential hydrophilicity and potency to
inhibit hydroxymethylglutaryl-CoA reductase that may be relevant to changes in adiponectin …

Amlodipine/atorvastatin (Caduet®) is a single-tablet, fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …

В настоящем обзоре представлена информация о современных возможностях
эффективной коррекции повышенного АД и дислипидемии с помощью использования у …

Deficiency of tetrahydrobiopterin (BH4) in the vascular tissue contributes to endothelial
dysfunction through reduced eNOS activity and increased superoxide anion (O2−) …

Background Lipid-lowering drugs and antihypertensive drugs are commonly combined for
cardiovascular disease (CVD). However, the relationship of combined medications with …